HST Global, Inc., an integrated biotechnology health and wellness company, announced today that it has commenced a project with EBITDA Capital, LLC for both shareholder participation and health and wellness center operations within Saudi Arabia.
EBITDA Capital, LLC will begin working with their contacts and clients within the Kingdom of Saudi Arabia. Key clientele within the Royal Family have shown interest in becoming shareholders in HSTC. They are also interested in operating a health and wellness clinic based within the Gulf Cooperation Council Countries (GCC). If one (or several) were to be built, they would include both for-profit and non-profit treatment facilities in support of HSTC’s late stage cancer applications. The company would be responsible for the training, maintenance and management development in these clinics.
Mr. Chet Noblett, Managing General Partner of EBITDA, is facilitating the initial negotiations and is leveraging his long term relationships with these parties. Mr. Noblett stated, “We have been cautiously opening the window of opportunity for HSTC with our associates in Saudi Arabia. Health care is a top priority throughout the GCC and HSTC offers the opportunity to energize the effort by establishing these clinics. We are very pleased to have the level of interest and acceptance that has been expressed at this time.”
Ron Howell, President and CEO of HST Global, Inc., commented, “The commencement of this initiative within the GCC Countries characterizes the essence of what HSTC is developing. The combined capital and strategic operational partnership will bring an affordable, yet cost effective treatment for late stage cancer to the GCC. HSTC is reaching across the Globe with its brand of alternative health and wellness centers.”
HSTC also told investors that it has plans to establish clinics modeled after the GCC project within a number of Asian markets where EBITDA has already made initial contacts.
Let us hear your thoughts: HST Global, Inc. Message Board